Search Page

1

Cite

Share

Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?

Montemagno C, Cassim S, De Leiris N, Durivault J, Faraggi M, Pagès G. Montemagno C, et al. Int J Mol Sci. 2021 Jun 15;22(12):6413. doi: 10.3390/ijms22126413. Int J Mol Sci. 2021. PMID: 34203923 Free PMC article. Review.

Cite

Share

2

Cite

Share

Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs.

Montemagno C, Pagès G. Montemagno C, et al. Front Cell Dev Biol. 2020 Jul 7;8:584. doi: 10.3389/fcell.2020.00584. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32775327 Free PMC article. Review.

Cite

Share

3

Cite

Share

Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine.

Montemagno C, Pagès G. Montemagno C, et al. Cancers (Basel). 2020 Mar 29;12(4):821. doi: 10.3390/cancers12040821. Cancers (Basel). 2020. PMID: 32235331 Free PMC article. Review.

Cite

Share

4

Cite

Share

Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma.

Pagnuzzi-Boncompagni M, Picco V, Vial V, Planas-Bielsa V, Vandenberghe A, Daubon T, Derieppe MA, Montemagno C, Durivault J, Grépin R, Martial S, Doyen J, Gavard J, Pagès G. Pagnuzzi-Boncompagni M, et al. Among authors: montemagno c. Cancers (Basel). 2021 Dec 24;14(1):70. doi: 10.3390/cancers14010070. Cancers (Basel). 2021. PMID: 35008234 Free PMC article.

Cite

Share

5

Cite

Share

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma.

Montemagno C, Cassim S, Pouyssegur J, Broisat A, Pagès G. Montemagno C, et al. Int J Mol Sci. 2020 Jun 6;21(11):4067. doi: 10.3390/ijms21114067. Int J Mol Sci. 2020. PMID: 32517181 Free PMC article. Review.

Cite

Share

6

Cite

Share

Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.

Dumond A, Montemagno C, Vial V, Grépin R, Pagès G. Dumond A, et al. Among authors: montemagno c. Cells. 2021 May 17;10(5):1222. doi: 10.3390/cells10051222. Cells. 2021. PMID: 34067671 Free PMC article.

Cite

Share

7

Cite

Share

In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor.

Montemagno C, Raes F, Ahmadi M, Bacot S, Debiossat M, Leenhardt J, Boutonnat J, Orlandi F, Barbato D, Tedesco M, Ghezzi C, Perret P, Broisat A. Montemagno C, et al. Cancers (Basel). 2021 Mar 2;13(5):1051. doi: 10.3390/cancers13051051. Cancers (Basel). 2021. PMID: 33801382 Free PMC article.

Cite

Share

8

Cite

Share

Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma.

Dumond A, Brachet E, Durivault J, Vial V, Puszko AK, Lepelletier Y, Montemagno C, Pagnuzzi-Boncompagni M, Hermine O, Garbay C, Lagarde N, Montes M, Demange L, Grépin R, Pagès G. Dumond A, et al. Among authors: montemagno c. J Exp Clin Cancer Res. 2021 Jan 18;40(1):33. doi: 10.1186/s13046-021-01832-x. J Exp Clin Cancer Res. 2021. PMID: 33461580 Free PMC article.

Cite

Share

9

Cite

Share

In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study.

Montemagno C, Serrano B, Durivault J, Nataf V, Mocquot F, Amblard R, Vial V, Ronco C, Benhida R, Dufies M, Faraggi M, Pagès G. Montemagno C, et al. Biochem Biophys Rep. 2021 Aug 12;27:101098. doi: 10.1016/j.bbrep.2021.101098. eCollection 2021 Sep. Biochem Biophys Rep. 2021. PMID: 34430714 Free PMC article.

Cite

Share

10

Cite

Share

Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?

Echavidre W, Picco V, Faraggi M, Montemagno C. Echavidre W, et al. Among authors: montemagno c. Pharmaceutics. 2022 May 13;14(5):1053. doi: 10.3390/pharmaceutics14051053. Pharmaceutics. 2022. PMID: 35631639 Free PMC article. Review.

Cite

Share